Navigation Links
Yongye International Announces Second Quarter 2012 Financial Results
Date:8/9/2012

BEIJING, Aug. 9, 2012 /PRNewswire-Asia-FirstCall/ -- Yongye International, Inc. (NASDAQ: YONG), ("Yongye" or the "Company") a leading developer, manufacturer, and distributor of crop nutrient products in the People's Republic of China ("PRC"), today announced its financial results for the quarter ended June 30, 2012.

Second Quarter 2012 Financial Highlights

  • Revenue increased 14.8% to $177.6 million from $154.7 million in the second quarter of 2
  • Gross profit increased 17.8% year-over-year to $108.1 million
  • Income from operations increased 3.9% to $53.5 million
  • Net income attributable to Yongye increased 4.0% to $41.1 million from $39.5 million for the same period of 2011. Diluted earnings per share for the quarter was $0.74, compared to $0.77 for the same period of 2011
  • Adjusted net income attributable to Yongye, which excludes non-cash expenses related to share-based compensation for management and independent directors, the amortization of the acquired Hebei customer list, and a change in the fair value of derivative liabilities, was $43.0 million, or $0.78 per diluted share, compared to $40.5 million, or $0.82 per diluted share, in the same period last year*
  • Cash flows from operating activities was $8.1 million for six months ended June 30, 2012, compared to cash flows used in operating activities of $(27.8) million in the same period of 2011
  • It is important to note that, since the fourth quarter of 2011, for those provincial-level distributors with prolonged payment records, the Company has recognized revenue upon the receipt of cash, instead of upon shipments.  We continue to provide these provincial-level distributors with six-month credit terms. During the second quarter of 2012, the Company primarily collected cash for sales to these distributors with shipments made in the fourth quarter of 2011, which is a non-peak season for us.  Consequently, a significant amount of sales and related profits were not recorded in the Company's financial statements.  Despite this fact, orders, shipments and the profitability of our business remain very strong.  The shipments of crop and animal nutrient products made by the Company in the second quarter of 2012 and 2011 were 18,300 tons and 13,349 tons, respectively, representing a 37.1% increase over the prior year quarter, while our selling prices have remained stable. We have collected all of the outstanding accounts receivable balance at the end of 2011. None of Yongye's distributors have an overdue accounts receivable balance at the end of this quarter.

    Mr. Zishen Wu, Chairman and Chief Executive Officer of Yongye International, stated, "The underlying fundamentals of our business are strong. Shipments increased 37.1% over the prior year quarter, and we continue to see robust demand for our Shengmingsu products. Additionally, we are particularly pleased with the solid performance of our two new liquid crop nutrient products, which is a testament to the strength of the Yongye brand. We also made significant progress with our capacity expansion efforts and mine exploration initiative during the quarter, both of which are consistent with our long-term strategy to realize significant competitive advantages and meet the growing demand for our products. With these initiatives in place and our expanding branded retailer network, I am confident that Yongye is well positioned for sustainable long-term growth."

    Second Quarter 2012 ResultsSales increased by $22.9 million, or 14.8%, to $177.6 million in the second quarter of 2012, from $154.7 million for the same period of 2011. In the second quarter of 2012, $176.3 million, or 99.3% of the total sales, were from the liquid crop nutrient, and $1.3 million, or 0.7% of the total sales, were from the powder animal nutrient. For the liquid crop nutrient, the original crop nutrient product contributed $155.6 million, or 88.2% of total liquid crop nutrient sales, while the two new products for crop seeds and roots contributed $20.7 million, or 11.8% of the total liquid crop nutrient sales. During the second quarter of 2012, the number of branded retailers increased from 30,886 to 32,015, with the majority of newly recruited branded retailers located in Hebei, Shanxi, Jiangsu and Henan provinces.

    Gross profit was $108.1 million in the second quarter of 2012, compared to $91.8 million in the same period of 2011, an increase of 17.8%.  Gross margin was 60.9% in the second quarter of 2012, compared to 59.3% for the same period of 2011. The increase in gross margin was mainly due to the decreased purchase price of certain raw materials.

    Selling expenses increased by $9.4 million, or 32.2%, to $38.6 million in the second quarter of 2012, from $29.2 million for the same period of 2011. The increase in selling expenses was primarily due to an increase in advertising and promotion expense, and distributors' seminar expenditure of $9.3 million related to marketing and promotional activities in our markets.

    General and administrative ("G&A") expenses increased by $3.0 million, or 54.8%, to $8.6 million in the second quarter of 2012, from $5.6 million for the same period of 2011. The increase in general and administrative expenses was mainly due to an increase in management equity compensation expenses and other administrative related expenditure for the three months ended June 30, 2012.

    Research and development ("R&D") expenses were $7.4 million in the second quarter of 2012, compared to $5.6 million for the same period of 2011. The R&D expenses mainly consisted of field testing expenses for new products and tests on different crops and in newly developed markets.

    Income from operations was $53.5 million in the second quarter of 2012, compared to $51.5 million in the same period of 2011. Excluding non-cash expenses related to share-based compensation for management and independent directors and the amortization of the acquired Hebei customer list, second quarter 2012 adjusted income from operations was $55.4 million, or 31.2% of sales.* The increase in income from operations was mainly due to the sales growth combined with lower purchase price of certain raw materials.

    Net income attributable to Yongye was $41.1 million, or $0.74 per diluted share in the second quarter of 2012, compared to a net income of $39.5 million, or $0.77 per diluted share, in the same period of 2011. The Company recorded non-cash income related to a change in fair value of derivative liabilities of $9,889 in the second quarter of 2012. Excluding the impact of non-cash expenses related to share-based compensation for management and independent directors, the amortization of the acquired Hebei customer list, and a change in the fair value of derivative liabilities, adjusted net income attributable to Yongye for the second quarter of 2012 was $43.0 million, or $0.78 per diluted share, compared to adjusted net income of $40.5 million, or $0.82 per diluted share in the same period of 2011.*

    Six Month Financial ResultsRevenue for the six months ended June 30, 2012 increased 18.1% to $242.0 million from $204.9 million for the comparable period in 2011, while gross profit was $143.5 million, compared to $119.1 million in the first six months of 2011. Gross margin was 59.3% for the six months ended June 30, 2012, as compared to 58.1% for the same period of 2011. Income from operations in the first six months of 2012 was $75.4 million, compared to $62.8 million in the first six months of 2011. Net income attributable to Yongye for the first six months of 2012 was $57.5 million, compared to $47.9 million in the prior year period. In the first six months 2012, net income per diluted share was $1.02, as compared to $0.94 diluted earnings per share for the same period of 2011.

    (*) See the table following this press release for a reconciliation of gross profit, income from operations, net income and diluted EPS to exclude non-cash items related to share-based compensation for management and independent directors, the amortization of the acquired Hebei customer list, and a change in the fair value of derivative liabilities to the comparable financial measure prepared in accordance with US Generally Accepted Accounting Principles ("U.S. GAAP"). 

    Financial ConditionAs of June 30, 2012, the Company had $82.0 million in cash and restricted cash, compared to $81.2 million as of December 31, 2011. Working capital was $329.6 million, compared to $270.4 million at the end of 2011. The Company had $25.3 million in short-term bank loans and $11.0 million in long-term debt as of June 30, 2012.  Stockholders' equity totaled $395.7 million as of June 30, 2012, compared to $331.9 million at the end of 2011. Cash flow provided by operating activities was $8.1 million and cash flow used in operating activities was $(27.8) million for the six months ended June 30, 2012 and 2011, respectively. The change was primarily due to the decrease of $31.7 million in working capital consumption. That was mainly driven by collection of accounts receivable, partially offset by a higher inventory balance. Other factor includes an increase of $9.6 million in earnings.

    Recent Developments

  • On June 8, 2012, the Company held its 2012 Annual Meeting of Shareholders at the Company's offices in Hohhot, Inner Mongolia, China. At the meeting, Yongye shareholders approved the reelection of Zishen Wu, Nan Xu, Xiaochuan Guo, Sean Shao, Xindan Li and Rijun Zhang as members of the Board of Directors for a one-year term expiring at the 2013 annual meeting of shareholders. Additionally, holders of the Company's Series A preferred shares reappointed Homer Sun as their designee to the Board of Directors and the Company's shareholders ratified the appointment of KPMG as the Company's independent auditors for the fiscal year ending December 31, 2012.
  • On April 3 2012, the Company provided an update on accounts receivable collection as of the quarter ended March 31, 2012. During the first quarter of 2012, the Company collected $140 million of $154 million accounts receivable, net of allowance for doubtful accounts at the end of the year of 2011. The Company has taken measures to increase its collection efforts and closely monitor its distributors' financial status.  In the second quarter of 2012, the Company collected the accounts receivable balance of $71 million including the remaining $14 million at the end of 2011. 
  • On March 23, 2012, the Company announced that it had launched two new fulvic acid based crop nutrient products, Zhongbaosheng and Qianggenbao, in the first quarter of 2012. The two products are complementary to Yongye's existing Shengmingsu products and help the Company break into the nutrient market for seed and root nutrient products in China. Both products were developed by the Company's industry leading research and development team, and have been successfully field tested extensively throughout China. 
  • On March 5, 2012, the lead plaintiffs in the previously announced class action lawsuit filed against the Company by Robbins Geller Rudman & Dowd LLP in the United States District Court Southern District of New York in May 2011 voluntarily dismissed by the suit with prejudice as to themselves as named plaintiffs. Yongye did not incur any material legal fees, charges or costs related to this class action lawsuit or its voluntary dismissal.
  • Business Outlook For the full year 2012, the Company reiterates its expected sales between $495 million and $515 million and adjusted net income between $110 million and $120 million, which excludes the impact of non-cash expenses related to share-based compensation for management and independent directors, the amortization of the acquired Hebei customer list, and a change in the fair value of derivative liabilities. The Company also expects that its branded retailer network will be expanded to 35,000 by the end of 2012, which represents a 16.3% increase over the 2011 year-end number of 30,086.

    Conference Call The Company will host a conference call at 8:30 a.m. Eastern Time on August 9, 2012, to discuss its second quarter and half year 2012 results.

    To participate in the live conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: +1 (866) 519-4004. International callers should dial +1 (718) 354-1231. The conference pass code is 175 57 831.

    For those who are unable to participate on the live conference call, a replay will be available for fourteen days starting from 11:30 a.m. Eastern Time on August 9 to 23:59 Eastern Time on August 23. To access the replay, please dial +1 (866) 214-5335. International callers should dial +1 (718) 354-1232. The replay pass code is 175 57 831. A webcast recording of the conference call will be accessible through Yongye's website at www.yongyeintl.com

    Use of Non-GAAP Financial MeasuresGAAP results for the three months and six months ended June 30, 2012 and 2011 include non-cash items related to share-based compensation for management and independent directors, the amortization of the acquired Hebei customer list, and a change in the fair value of derivative liabilities.  To supplement the Company's condensed consolidated financial statements presented on a U.S. GAAP basis, the Company has provided adjusted financial information excluding the impact of these items in this release. Such adjustment is a departure of U.S. GAAP; however, the Company's management believes that these adjusted measures provide investors with a better understanding of how the results relate to the Company's historical performance. These adjusted measures should not be considered an alternative to net income, or any other measure of financial performance or liquidity presented in accordance with U.S. GAAP.  These measures are not necessarily comparable to a similarly titled measure of another company. A reconciliation of the adjustments to U.S. GAAP results appears in the table accompanying this press release. This additional adjusted information is not meant to be considered in isolation or as a substitute for U.S. GAAP financials. The adjusted financial information that the Company provides also may differ from the adjusted information provided by other companies.

    About Yongye International, Inc.Yongye International, Inc. is a leading crop nutrient company headquartered in Beijing, with its production facilities located in Hohhot, Inner Mongolia, China. Yongye's principal product is a liquid crop nutrient, from which the Company derived substantially all of the sales in 2011. The Company also produces powder animal nutrient product which is mainly used for dairy cows. Both products are sold under the trade name "Shengmingsu," which means "life essential" in Chinese. The Company's patented formula utilizes fulvic acid as the primary compound base and is combined with various micro and macro nutrients that are essential for the health of the crops. The Company sells its products primarily to provincial level distributors, who sell to the end-users either directly or indirectly through county-level and village-level distributors. For more information, please visit the Company's website at www.yongyeintl.com.

    Safe Harbor StatementThis press release contains certain statements that may include "forward-looking statements." All statements other than statements of historical fact included herein are "forward-looking statements." These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, involving known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including the risk factors discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on the SEC's website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these risk factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.

    ContactsYongye International, Inc.
    Ms. Kelly Wang
    Finance Director - Capital Markets
    Phone: +86-10-8231-9608
    E-mail: ir@yongyeintl.com

    Ms. Wendy Xuan
    Business Associate
    Phone: +86-10-8232-8866 x 8827
    E-mail: ir@yongyeintl.com

    FTI Consulting
    Mr. John Capodanno (U.S. Contact)
    Phone: +1-212-850-5705
    E-mail: john.capodanno@fticonsulting.com

     

    (Financial Tables to Follow)  YONGYE INTERNATIONAL, INC. AND SUBSIDIARIES UNAUDITED CONSOLIDATED BALANCE SHEETS June 30, 2012December 31, 2011Current assetsCash

    US$

    81,952,040US$

    81,154,880Restricted cash40,00040,000Accounts receivable, net of allowance for doubtful accounts188,359,652153,629,522Inventories103,720,61486,117,000Deposits to suppliers25,240,4302,664,360Prepaid expenses774,3724,954,359Other receivables253,299385,263Deferred tax assets1,349,9742,283,388Total Current Assets401,690,381331,228,772Property, plant and equipment, net21,787,89021,929,444Intangible asset, net20,346,86021,649,890Land use right, net6,111,9716,129,151Prepayment for mining project35,760,10035,511,520Other assets44,682,48631,621,465Goodwill10,769,49910,694,636Total Assets541,149,187458,764,878Current liabilitiesShort-term bank loans25,339,30928,308,563Long-term loans and payables - current portion7,518,5934,279,234Accounts payable12,175,25613,098,183Income tax payable8,802,5493,161,538Advance from customers138,9514,095,580Accrued expenses14,888,3974,437,220Other payables2,956,6233,159,070Derivative liabilities - fair value of warrants247,896317,183Total Current Liabilities72,067,57460,856,571  Long-term loans and payables11,036,2847,464,683  Other non-current liability 4,327,9274,297,842  Deferred tax liabilities6,831,8274,857,800Total Liabilities94,263,61277,476,896Redeemable Series A convertible preferred shares: par value $.001; 7,969,044  shares authorized; 6,079,545 shares and 5,681,818 shares issued and outstanding as of June 30, 2012 and December 31, 2011, respectively51,208,657

    49,399,990EquityCommon stock: par value $.001; 75,000,000 shares authorized; 49,370,711 shares issued and
    outstanding at June 30, 2012 and December 31, 2011, respectively49,37149,371Additional paid-in capital153,079,165150,654,849Retained earnings204,488,483148,804,997Accumulated other comprehensive income19,594,21217,078,758 Total equity attributable to Yongye International, Inc.377,211,231316,587,975Noncontrolling interest18,465,68715,300,017 Total Equity395,676,918331,887,992Commitments and Contingencies--Total Liabilities, Redeemable Series A Convertible Preferred Shares and Equity541,149,187458,764,878 

    YONGYE INTERNATIONAL, INC. AND SUBSIDIARIES UNAUDITED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOMEFor the Three Months Ended

    For the Six Months EndedJune 30, 2012June 30, 2011June 30, 2012June 30, 2011Sales

     US$

    177,625,986 US$

    154,704,865 US$

    241,991,630 US$

    204,926,076Cost of sales69,535,73362,939,17498,488,87285,860,458Gross profit108,090,25391,765,691143,502,758119,065,618Selling expenses38,554,59029,152,92352,757,64736,834,243Research and development expenses7,384,8045,555,6348,893,5426,608,614General and administrative expenses (including a reversal of allowance for doubtful accounts of US$6,334,832 and nil for six months ended June 30, 2012 and 2011, respectively)8,646,7635,586,0196,437,29212,864,324Income from operations53,504,09651,471,11575,414,27762,758,437Other income/(expenses)Interest expense(1,102,126)(291,751)(2,106,295)(309,862)Interest income75,33616,860135,41027,164Subsidy income-655,071-655,071Other income, net2,66226,56034,716101,619Change in fair value of derivative liabilities9,88983,43569,287413,587Total other (expenses) /income, net(1,014,239)490,175(1,866,882)887,579Earnings before income tax expense52,489,85751,961,29073,547,39563,646,016Income tax expense9,272,20610,127,25513,012,42812,760,047Net income43,217,65141,834,03560,534,96750,885,969Less: Net income attributable to the noncontrolling interest2,107,7882,297,2713,042,8142,982,777Net income attributable to Yongye International, Inc.41,109,86339,536,76457,492,15347,903,192Net income per share of common stock:Basic0.750.781.020.95Diluted0.740.771.020.94Weighted average shares used in computation:Basic49,370,71149,276,07049,370,71148,734,565Diluted49,445,17649,378,39649,453,57248,845,281Net income43,217,65141,834,03560,534,96750,885,969  Other comprehensive incomeForeign currency translation adjustment, net of nil income taxes297,0593,845,4902,638,3105,672,157Comprehensive income43,514,71045,679,52563,173,27756,558,126Less: Comprehensive income attributable to the noncontrolling interest2,121,7752,469,1673,165,6703,234,579Comprehensive income attributable to Yongye International, Inc.41,392,93543,210,35860,007,60753,323,547 

     

    YONGYE INTERNATIONAL, INC. AND SUBSIDIARIESUNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWSFor the Six Months EndedJune 30, 2012June 30, 2011CASH FLOWS FROM OPERATING ACTIVITIESNet income

    US$

    60,534,967US$

    50,885,969Adjustments to reconcile net income to net cash provided by/(used in) operating activities:Depreciation and amortization7,072,5223,261,186Reversal of allowance for doubtful accounts(6,334,832)-Change in fair value of derivative liabilities(69,287)(413,587)Stock compensation expense2,424,3164,950,600Deferred tax expense300,108162,234Changes in operating assets and liabilities:Accounts receivable(27,170,173)(115,140,649)Inventories(17,028,433)23,582,770Deposit to suppliers(22,118,726)(41,373,219)Prepaid expenses4,212,958(693,128)Other receivables134,726(5,805)Other assets(5,099,274)(1,995,399)Accounts payable(1,002,120)12,662,550Income tax payable5,610,2048,251,950Advance from customers(3,988,722)606,546Accrued expenses10,413,69126,366,405Other payables193,6331,108,043Net Cash Provided by/(Used in) Operating Activities8,085,558(27,783,534)CASH FLOWS FROM INVESTING ACTIVITIESPayment for intangible asset-(3,000,000)Purchase of property, plant and equipment(1,449,852)(1,608,789)Net Cash Used in Investing Activities(1,449,852)(4,608,789)CASH FLOWS FROM FINANCING ACTIVITIESProceeds from short-term bank loans25,318,85915,384,852Repayment of long-term loans and payables(3,091,865)(351,242)Repayment of short-term bank loans(28,483,717)-Proceeds from preferred shares, net of issuance cost of $600,010-49,399,990Net Cash (Used in)/Provided by Financing Activities(6,256,723)64,433,600EFFECT OF FOREIGN EXCHANGE RATE CHANGES ON CASH418,177878,510NET INCREASE IN CASH797,16032,919,787Cash at beginning of period81,154,88041,913,469Cash at end of period81,952,04074,833,256Supplemental cash flow information:Cash paid for income taxes7,128,0664,345,862Cash paid for interest expense2,069,219309,862Noncash investing and financing activities:Acquisition of property, plant and equipment included in other payables422,7541,081,041Acquisition of other assets by assuming long-term loans and payables 9,820,9301,977,956Paid-in-kind dividends on redeemable Series A convertible preferred shares1,808,667- 

     

    YONGYE INTERNATIONAL, INC. AND SUBSIDIARIESRECONCILIATION OF NON-GAAP FINANCIAL DATAGross ProfitThree Months Ended June 30,Six Months Ended June 30,2012

    20112012

    2011GAAP amount per consolidated statement of income

    $108,090,253

    $91,765,691$143,502,758

    $119,065,618Amortization of the acquired Hebei customer list

    $723,827

    $703,727$1,448,871

    $1,398,845Adjusted Amount

    $108,814,080

    $92,469,418$144,951,629

    $120,464,463Income from OperationsThree Months Ended June 30,Six Months Ended June 30,2012

    20112012

    2011GAAP amount per consolidated statement of income

    $53,504,096

    $51,471,115$75,414,277

    $62,758,437Amortization of the acquired Hebei customer list

    $723,827

    $703,727$1,448,871

    $1,398,845Non-cash management compensation expense

    $1,212,158

    $370,866$2,424,316

    $4,950,600Adjusted Amount

    $55,440,081

    $52,545,708$79,287,464

    $69,107,882Net income (attributable to Yongye)Three Months Ended June 30,Six Months Ended June 30,2012

    20112012

    2011GAAP amount per consolidated statement of income

    $41,109,863

    $39,536,764$57,492,153

    $47,903,192Amortization of the acquired Hebei customer list

    $723,827

    $703,727$1,448,871

    $1,398,845Non-cash management compensation expense

    $1,212,158

    $370,866$2,424,316

    $4,950,600Change in fair value of derivative liabilities

    ($9,889)

    ($83,435)($69,287)

    ($413,587)Adjusted Amount

    $43,035,959

    $40,527,922$61,296,053

    $53,839,050Weighted average shares -- diluted

    49,445,176

    49,378,39649,453,572

    48,845,281Adjusted diluted earnings per share

    $0.78

    $0.82$1.09

    $1.10 

     


    '/>"/>
    SOURCE Yongye International, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved


    Related biology technology :

    1. Yongye International to Report Second Quarter 2012 Financial Results on August 9, 2012
    2. Dyadic International to Announce Second Quarter 2012 Financial Results and Host Conference Call on Monday, August 13, 2012
    3. SRI International Researchers Developing Bioadhesive Gel to Protect Women from HIV and HSV Infections
    4. Elsevier Launches International Journal for Parasitology: Parasites and Wildlife
    5. Bio-Innovator Saneron CCEL Therapeutics Supports Cryo-Cell International Leadership and Board of Directors in Proxy Contest
    6. Bunker Hill Community College Student Speaks at 2012 BIO International Convention
    7. International Probiotics Association Excited To Learn The FDA Has Decided To Issue A New, Revised NDI Draft Guidance
    8. Promoting the States Quality of Life, New Jersey Symphony Orchestra to Perform at BIO International Convention
    9. International Survey of T2* Cardiovascular Magnetic Resonance in Thalassemia
    10. PAREXEL International To Present At Goldman Sachs Healthcare Conference And Jefferies Healthcare Conference
    11. QIAGEN Acquires AmniSure International to Add Unique Assay to Emerging Point of Need Portfolio
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/3/2016)... LONDON , May 3, 2016 ... Report Assessing Developers and Producers of Those Competitor Biologics  ... Guide to Companies, Activities and Prospects ,  ... drug companies? And what are their sales potentials? ... There you see results, trends, opportunities and revenue forecasting. ...
    (Date:5/2/2016)... 2016 Q BioMed Inc. (QBIO), ... Mannin Research Inc. will be attending the Association for ... from May 1-5, 2016 in Seattle Washington ... its vendors and research partners. The meeting provides organizations ... other collaborative opportunities for the MAN-01 program for treatment ...
    (Date:4/29/2016)... Como, Italy (PRWEB) , ... April 30, 2016 , ... ... their extraordinary textile design, the bioLogic team explored how bacterial properties can be applied ... ways of using Natto bacteria, which move in response to humidity change. The team ...
    (Date:4/29/2016)... CO (PRWEB) , ... April 29, 2016 , ... ... addressing the necessary fundamentals to transform technology into a viable company, CereScan’s CEO, ... growth. Mr. Kelley, a recognized leader and mentor in the Denver area ...
    Breaking Biology Technology:
    (Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
    (Date:4/15/2016)... Research and Markets has announced ... 2016-2020,"  report to their offering.  , ... global gait biometrics market is expected to grow ... 2016-2020. Gait analysis generates multiple variables ... to compute factors that are not or cannot ...
    (Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
    Breaking Biology News(10 mins):